Liying Liu

983 citations
52 papers · 744 indexed · h-index 16
Topics
Natural Antidiabetic Agents Studies (4 papers)Ovarian cancer diagnosis and treatment (4 papers)Fungal Biology and Applications (4 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Liying Liu

50 papers receiving 731 citations

Peers

Liying Liu
Comparison fields: 5 of 118
  • Molecular Biology 196
  • Plant Science 101
  • Surgery 94
  • Pharmacology 94
  • Complementary and alternative medicine 88
Replace M. Mathy‐Hartert with:
M. Mathy‐Hartert Belgium
Ibeth Guevara Poland
Yuwei Yang China
Tomoaki Inazumi Japan
Ling Xu China
Andrea Braganza United States
Shyi‐Wu Wang Taiwan
Kyung‐Woon Kim South Korea
Yumeng Li China
Yu‐Cheng Chou Taiwan
Liying Liu relative to M. Mathy‐Hartert Belgium M. Mathy‐Hartert's profile →
Citations per field
00.5×1.5×2.5×
M. Mathy‐Hartert · 1×
Citations per year

Countries citing papers authored by Liying Liu

Since Specialization
Citations

This map shows the geographic impact of Liying Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liying Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liying Liu more than expected).

Fields of papers citing papers by Liying Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liying Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liying Liu. The network helps show where Liying Liu may publish in the future.

Co-authorship network of co-authors of Liying Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Liying Liu. A scholar is included among the top collaborators of Liying Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liying Liu. Liying Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 1
4 12
5 3
6 13
7 14
8 5
9 4
10 26
11 68
12 26
13 32
14 52
15 55
16 1
17 21
18 3
19 0
20 6

About Liying Liu

Liying Liu is a scholar working on Pharmacology, Biochemistry and Complementary and alternative medicine, having authored 52 papers that have together received 744 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Fungal Biology and Applications (4 papers). The work is most often cited by research in Complementary and alternative medicine (88 citations), Biochemistry (48 citations) and Pharmacology (55 citations). Liying Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ruo-Yun Chen, Gentu Ge, Yushan Jia, Hongqing Wang, Xiao-Ming Xiong, Erbin Dai, Yinghao Liu, Wei Wang, Jie Kang and Elliot L. Chaikof. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026